Paper901706
Pindolol, a beta-adrenoceptor blocking agent with a negligible first-pass effect.
Meier J and 1 other. Br J Clin Pharmacol, 1977. Cited by 21 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pindolol, a beta-adrenoceptor blocking agent with a negligible first-pass effect. Papers, record 901706. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/901706
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pindolol | Major topic |
| Administration, Oral | |
| Biological Availability | |
| Biotransformation | |
| Humans | |
| Injections, Intravenous | |
| Kinetics | |
| Male |
Source PubMed
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 13,958 | Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs. | Clin Pharmacokinet | 1976 | https://conductscience.org/library/papers/13958 | PubMed |
| 2 | 973,959 | beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers. | Br J Clin Pharmacol | 1976 | https://conductscience.org/library/papers/973959 | PubMed |
| 3 | 1,136,801 | Proceedings: "First-pass" effect and dose dependent availability as factors contributing to interindividual differences in equilibrium concentrations of alprenolol in man. | Acta Pharm Suec | 1974 | https://conductscience.org/library/papers/1136801 | PubMed |
| 4 | 5,567,579 | Influence of first-pass effect on availability of drugs on oral administration. | J Pharm Sci | 1971 | https://conductscience.org/library/papers/5567579 | PubMed |
| 5 | 4,390,683 | A method for the fluorimetric determination of 4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB46), a beta-blocking agent, in plasma and urine. | Experientia | 1969 | https://conductscience.org/library/papers/4390683 | PubMed |
| 6 | 237,402 | Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol. | Acta Pharmacol Toxicol (Copenh) | 1975 | https://conductscience.org/library/papers/237402 | PubMed |
| 7 | 4,853,607 | Pharmacokinetics of unlabelled and 14C-labelled pindolol in uraemia. | Eur J Clin Pharmacol | 1974 | https://conductscience.org/library/papers/4853607 | PubMed |
| 8 | 4,853,602 | Pharmacokinetics of pindolol in man. | Eur J Clin Pharmacol | 1974 | https://conductscience.org/library/papers/4853602 | PubMed |
| 9 | 5,054,586 | The disposition of propranolol. I. Elimination during oral absorption in man. | Pharmacology | 1972 | https://conductscience.org/library/papers/5054586 | PubMed |
| 10 | 1,094,802 | Combined pharmacokinetic and pharmacodynammc studies in man of the adrenergic beta1-receptor antagonist metoprolol. | Acta Pharmacol Toxicol (Copenh) | 1975 | https://conductscience.org/library/papers/1094802 | PubMed |
| 11 | 1,137,681 | Proceedings: Biological and pharmacological myocardial elimination rate of propranolol. | Br Heart J | 1975 | https://conductscience.org/library/papers/1137681 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34,196,913 | Changes of Drug Pharmacokinetics in Patients with Short Bowel Syndrome: A Systematic Review. | Eur J Drug Metab Pharmacokinet | 2021 | https://conductscience.org/library/papers/34196913 | PubMed |
| 25,432,141 | Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds. | Crit Care | 2014 | https://conductscience.org/library/papers/25432141 | PubMed |
| 7,286,035 | A pharmacodynamic and pharmacokinetic comparison of pindolol 20 mg retard and a conventional tablet. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7286035 | PubMed |
| 7,117,354 | Metabolism of pindolol in patients with renal failure. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7117354 | PubMed |
| 7,106,158 | Elimination of pindolol in liver disease. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7106158 | PubMed |
| 7,104,143 | Effects of age and smoking on the pharmacokinetics of pindolol and propranolol. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7104143 | PubMed |
| 7,104,142 | Cardiac dose-response relationships of oral and intravenous pindolol. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7104142 | PubMed |
| 7,014,827 | A standard approach to compiling clinical pharmacokinetic data. | J Pharmacokinet Biopharm | 1981 | https://conductscience.org/library/papers/7014827 | PubMed |
| 6,487,506 | Study of the bioavailability of pindolol in malabsorption syndromes. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6487506 | PubMed |
| 6,125,169 | Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6125169 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/901706
GET https://conductscience.org/api/papers/v1/901706/authors